Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract CT170: Initial safety and feasibility results from a first-in-human clinical trial evaluating a novel magnetic hyperthermia approach for the treatment of metastatic solid tumors

Sarah Kraus, Cheri Tal, Boaz Shalev, Moshe Eltanani, Pazit Rukenstein, Shir Arbib, Michal Eck, Raz Khandadash, Shaul Atar, Arnoldo Cyjon, Ofer Shalev

Cancer Res (2023) 83 (8_Supplement): CT170.

https://doi.org/10.1158/1538-7445.AM2023-CT170

Published: 14 April 2023

View article titled, Abstract CT170: Initial safety and feasibility results from a first-in-human clinical trial evaluating a novel magnetic hyperthermia approach for the treatment of metastatic solid tumors

Journal Articles

Abstract 1004: Impact of genetic polymorphisms on colorectal adenoma recurrence and toxicity in a COX-2 inhibitor trial (Celecoxib): Results from a pilot study

Simone Hummler, Sarah Kraus, Adetunji T. Toriola, Elizabeth M. Poole, Jana Kotzmann, Karen M. Makar, Dina Kazanov, Lior Galazan, Inna Naumov, David Duggan, Nadir Arber, Cornelia M. Ulrich

Cancer Res (2012) 72 (8_Supplement): 1004.

https://doi.org/10.1158/1538-7445.AM2012-1004

Published: 15 April 2012

View article titled, Abstract 1004: Impact of genetic polymorphisms on colorectal adenoma recurrence and toxicity in a COX-2 inhibitor trial (Celecoxib): Results from a pilot study

Journal Articles

Abstract 593: Abusing oncogenic RAS to selectively target colorectal and pancreatic cancer cells

Inna Naumov, Victoria Lisiansky, Dina Kazanov, Shiran Shapira, Sarah Kraus, Nadir Arber

Cancer Res (2010) 70 (8_Supplement): 593.

https://doi.org/10.1158/1538-7445.AM10-593

Published: 15 April 2010

View article titled, Abstract 593: Abusing oncogenic <em>RAS</em> to selectively target colorectal and pancreatic cancer cells

Journal Articles

Abstract 5333: Novel Ab treatment tool for CRC

Shiran Shapira, Sarah Kraus, Dina Kazanov, Rolf Stahel, Irai Benhar, Nadir Arber

Cancer Res (2010) 70 (8_Supplement): 5333.

https://doi.org/10.1158/1538-7445.AM10-5333

Published: 15 April 2010

View article titled, Abstract 5333: Novel Ab treatment tool for CRC

Journal Articles

Abstract #1724: CD24 is a potential target for treatment of colorectal and pancreatic cancers

Shiran Shapira, Inna Naumov, Eyal Sagiv, Diana Kazanov, Sarah Kraus, Nadir Arber

Cancer Res (2009) 69 (9_Supplement): 1724.

Published: 01 May 2009

View article titled, Abstract #1724: CD24 is a potential target for treatment of colorectal and pancreatic cancers

Journal Articles

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Sarah Kraus, Daniel Gioeli, Tomas Vomastek, Vicki Gordon, Michael J. Weber

Cancer Res (2006) 66 (22): 11047–11054.

https://doi.org/10.1158/0008-5472.CAN-06-0596

Published: 15 November 2006

View article titled, Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Journal Articles

Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: Role of c-Jun NH₂-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways

Sarah Kraus, Gal Levy, Tamar Hanoch, Zvi Naor, Rony Seger

Cancer Res (2004) 64 (16): 5736–5744.

https://doi.org/10.1158/0008-5472.CAN-04-1156

Published: 16 August 2004

View article titled, Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: <subtitle>Role of c-Jun NH<sub>2</sub>-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways</subtitle>

NARROW

Abstract CT170: Initial safety and feasibility results from a first-in-human clinical trial evaluating a novel magnetic hyperthermia approach for the treatment of metastatic solid tumors

Abstract 1004: Impact of genetic polymorphisms on colorectal adenoma recurrence and toxicity in a COX-2 inhibitor trial (Celecoxib): Results from a pilot study

Abstract 593: Abusing oncogenic RAS to selectively target colorectal and pancreatic cancer cells

Abstract 5333: Novel Ab treatment tool for CRC

Abstract #1724: CD24 is a potential target for treatment of colorectal and pancreatic cancers

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: Role of c-Jun NH₂-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways

Email alerts

AACR Journals

Abstract CT170: Initial safety and feasibility results from a first-in-human clinical trial evaluating a novel magnetic hyperthermia approach for the treatment of metastatic solid tumors

Abstract 1004: Impact of genetic polymorphisms on colorectal adenoma recurrence and toxicity in a COX-2 inhibitor trial (Celecoxib): Results from a pilot study

Abstract 593: Abusing oncogenic RAS to selectively target colorectal and pancreatic cancer cells

Abstract 5333: Novel Ab treatment tool for CRC

Abstract #1724: CD24 is a potential target for treatment of colorectal and pancreatic cancers

Receptor for Activated C Kinase 1 (RACK1) and Src Regulate the Tyrosine Phosphorylation and Function of the Androgen Receptor

Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: Role of c-Jun NH2-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Gonadotropin-Releasing Hormone Induces Apoptosis of Prostate Cancer Cells: Role of c-Jun NH₂-Terminal Kinase, Protein Kinase B, and Extracellular Signal-Regulated Kinase Pathways